Onpattro 2 mg/ml
As listed in the register: Onpattro 2 mg/ml, Konzentrat zur Herstellung einer Infusionslösung
2 mg/ml ·
- Prescription only
- Pain, sleep, mood, epilepsy and the brain
- Active substance
- Patisiranum
- Made by
- Alnylam Switzerland GmbH
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Onpattro wird zur Behandlung der hereditären Transthyretin-Amyloidose (hATTR-Amyloidose) bei erwachsenen Patienten mit Polyneuropathie der Stadien 1 oder 2 angewendet
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Alnylam Switzerland GmbH |
|---|---|
| Active substance | Patisiranum |
| Used in | Pain, sleep, mood, epilepsy and the brain |
| Strength | 2 mg/ml |
| Classification | N07XX12 · Pain, sleep, mood, epilepsy and the brain |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | Onpattro 2 mg/ml, Konzentrat zur Herstellung einer Infusionslösung |
| Packs | 1 Durchstechflasche(n) |
| Zulassungsnummer | 67304 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.